Latest Microchannel Tech Cp (MCTC) Headlines
Post# of 4
BioLight Raises NIS 19 Million, Announces China Regulatory Approval for IOPtiMate(TM) for Glaucoma Surgery
PR Newswire - Thu Mar 06, 11:07AM CST
BioLight Israeli Life Sciences Investments Ltd. (TASE: BOLT; OTCQX: BLGTY), a firm that invests in, manages and commercializes biomedical innovations grouped into clusters around defined medical conditions, announces the successful completion of an equity financing that raised gross proceeds of approximately NIS 19 million (USD 5.5 million).